当前位置：
首页
>
产品中心 >
Functional_antibody >
Biosensis/抗淀粉样β肽（A-β40/42），[MOAB-2]-生物素化/M-1742-50-B/50µg的小鼠单克隆抗体
![Biosensis/抗淀粉样β肽（A-β40/42），[MOAB-2]-生物素化/M-1742-50-B/50µg的小鼠单克隆抗体](https://www.ebiomall.cn/images/biosensis/201712/M-1742-50-B_IHC_2.jpg)
Biosensis/抗淀粉样β肽（A-β40/42），[MOAB-2]-生物素化/M-1742-50-B/50µg的小鼠单克隆抗体
商品编号：
M-1742-50-B
品牌：
Biosensis inc
市场价：
¥5940.00
美元价：
3564.00
产品分类：
功能性抗体
公司分类：
Functional_antibody
联系Q Q：
3392242852
电话号码：
4000-520-616
电子邮箱：
info@ebiomall.com
商品介绍
| Description | TheamyloidbetapeptideisderivedfromthecleavageoftheAmyloidprecursorprotein(APP)andvariesinlengthfrom39to43aminoacids.However,theform(s)ofamyloid-betapeptide(Aβ)associatedwiththepathologycharacteristicofAlzheimersdisease(AD)remainsunclear.Inparticular,theneurotoxicityofintraneuronalAβaccumulationisanareaofconsiderableresearchandcontroversyprincipallybecauseantibodiesthoughttobespecificforAβhavebeenshowntoactuallydetectintraneuronalAPPandnotAβexclusively. MOAB-2(mouseIgG2b)isapan-specific,high-titerantibodytoAβresidues1-4asdemonstratedbybiochemicalandimmunohistochemicalanalyses(IHC),andishighlyspecificjusttoamyloidbetapeptide.MOAB-2didnotdetectAPPorAPP-CTFsincellculturemedia/lysates(HEK-APPSweorHEKAPPSwe/BACE1)orinbrainhomogenatesfromtransgenicmiceexpressing5familialAD(FAD)mutation(5xFADmice). UsingIHCon5xFADbraintissue,MOAB-2immunoreactivityco-localizedwithC-terminalantibodiesspecificforAβ40andAβ42.MOAB-2didnotco-localizewitheitherN-orC-terminalantibodiestoAPP.Inaddition,noMOAB-2-immunreactivitywasobservedinthebrainsof5xFAD/BACE-/-mice,althoughsignificantamountsofAPPweredetectedbyN-andC-terminalantibodiestoAPP,aswellasby6E10.Inboth5xFADand3xTgmousebraintissue,MOAB-2co-localizedwithcathepsin-D,aMarkerforacidicorganelles,furtherevidenceforintraneuronalAβ,distinctfromAβassociatedwiththecellmembrane.MOAB-2demonstratedstrongintraneuronalandextra-cellularimmunoreactivityin5xFADand3xTgmousebraintissues. BiosensisnowoffersbiotinylatedMOAB-2antibodyallowingmoreflexibilityinexperimentaldesignbyusingthebiotin-avidin/streptavidindetectionmethod.BiotinylatedMOAB-2antibodymayalsohelptoreducebackgroundstainingindifficult-to-staintissuesandincreasedetectionsensitivity.TheABIlityofbiotinylatedMOAB-2antibodytodetectamyloidbetahasbeenvalidatedbyIHC. Purified,non-biotinylatedMOAB-2antibodyisavailablehere. |
| Relatedproducts | Purified,non-biotinylatedMOAB-2antibody,cat#M-1586-100 OligomericAβELISAKit,cat#BEK-2215-1P/2P |
| BatchNo. | Seeproductlabel |
| Unitsize | 50µg |
| Antigen | Recombinanthumanamyloidbetaprotein42(Aβ42):DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA |
| AntigenLocation | Epitopemapstoresidues1-4ofhumanamyloidbetapeptide40/42 |
| AntigenLength | 42aminoacids |
| AntibodyType | Mousemonoclonal |
| Isotype | IgG2b,lamBDa |
| Clone | MOAB-2 |
| OtherNames | Beta-APP42;Beta-APP40;Beta-amyloidprotein42;Beta-amyloidprotein40;ABPP;APPI;AmyloidbetaA4protein;MOAB2;MOAB-2;Alzheimer"santibody;AB40;AB42;abeta |
| Accession | P05067A4_HUMAN |
| Producedin | Mouse |
| MolecularWeight | WithFormicacidextractionsandstandardreducingwesternblottingprocedures,beta-amyloidpeptidemigratesbetween3-6kDa(seeFigure1). |
| Purity | AntibodywaspurifiedfromcellculturesupernatantbyProteinGchromatography,biotinylatedandbuffer-exchangedintoPBS,pH7.4buffer |
| Applications | ThebiotinylatedMOAB-2antibodyhasbeentestedbyIHC(1:5001:2,000dilution)andisalsoexpectedtoworkinapplicationsvalidatedfortheunlabelledantibody(M-1586-100)atsameorhigherdilutions:WesternBlotting(WB),Immunohistochemistry(IHC),Immunohistochemistry/paraffinembeddedIHC(P),Immunoprecipitation(IP),Immunofluorescence(IF),ELISA. WesternBlotting: MOAB-2hasbeentestedinWBusingpurifiedsyntheticbeta-amyloidpreparationsandfromtransgenicmousebrainformicacidextracts(seeFigure1).Formicacidextraction/concentrationisrequiredforwesternblotdetectionfromextracts.Suggesteddilutionof1:2000-1:5,000forWB,standardECLdetectionsystems. Tissuesamplesforthedetectionofbeta-amyloidshouldbepreparedasdetailedinYoumansKLetal.,2011(JournalofNeuroscienceMethods196:5159)forbestresults.Detectionofbeta-amyloid40/42indirectwesternscanbedifficult;Dot-blotsofpreparedsamplesarerecommendedasdetailedinYoumansKLetal.,2012. Immunohistochemistry: SuggesteddilutionforbiotinylatedMOAB-2inIHCis1:500-1:2,000.Freshfrozen,4%paraformaldehydefixedfrozen,orformalinfixedparaffinembeddedtissuesareallsuitable.Antigenretrievalisrequiredinfixedtissuesforoptimalstaining. Antibodywastestedon4%paraformaldehyde/0.1%glutaraldehydefixedfrozentissuefrom3xTgand5xFADmice.MOAB-2antibodydetectsintraneuronalandextracellularbeta-amyloidinIHCanddoesnotdetectAPP(YoumansKLetal.,2012). Theantibodyalsoreactswitharchivalformalin-fixed,paraffin-embeddedtissuesampleswithantigenHeatInducedEpitopeRetrieval(HIER).RecommendedbufferforHIERiscitrate,pH6.0.Signalwasweakwithoutantigenretrieval.Immunoreactivitywasobservedinintraneural-amyloiddeposition(plaque)inAlzheimersbrain.MOAB-2wasfoundtobeextremelycleanandwithanexcellentsignaltonoiseratiowithnoneuro-cellulardiffusivestaining. Inaddition,MOAB-2demonstratednosignificantdifferencesinAβdetectionusingparaffinfixed,free-floatingsections(YoumansKLetal.,2012).Formicacid(FA)treatmentresultedinoptimaldetectionofbothintraneuronalandextracellularAβcomparedtowithoutFA(incubatedin88%FA8min,YoumansKLetal.,2012).FreefloatingtissuesectionswerepermeabilizedinTBScontaining0.25%TritonX-100(TBSX;3×10min),blockedwith3%horseseruminTBSX(3×10min)followedby1%horseseruminTBSX(2×10min)andincubatedwithappropriateprimaryantibodiesdilutedinTBSXcontaining1%horseserumovernight.SeeYoumansKLetal.,2012,forfullIHC(P)protocolandmethoddetails. Immunofluorescence: ForIF,suggesteddilutionis1:100-1:500.Theantibodywastestedon4%PFAfixedfrozentissue.FixedtissueswerewashedinTBS(3×10min),thenincubatedin88%FA(8min),andthenpermeabilizedinTBSX(3×10min),andblockedinTBSXcontaining5%bovineserumalbumin(BSA;1hr).SectionsweresubsequentlyincubatedwithappropriateprimaryantibodiesdilutedinTBSXcontaining2%BSAovernightonanoscillatoryrotator.Detectionwasviafluorescentlylabelledabsorbedsecondaryantibodies(YoumansKLetal.,2012). Immunoprecipitation: ForIP,thesuggesteddilutionis1:200to1:1,000forlabelledbeta-amyloidusingSA-coatedbeadsasthecapturevehicle,similartotheprotocolsemployedbyYoumansKLetal.,2012. ELISA: InanELISA,adilutionof1:50-1:1,000issuggested.TheantibodyhasbeentestedinELISAsonsyntheticbeta-amyloidandtissuehomogenatesfrombeta-amyloid-Tgmice. Biosensisrecommendsoptimaldilutions/concentrationsshouldbedeterminedbytheenduserforallapplications.Dilutionsprovidedareonlymeanttoserveasabasicguide. |
| Specificity | MOAB-2detectspreparationsenrichedinU-,O-,F-Aβ42,andU-Aβ40bydot-blot,andisthusapan-specificAβantibody.However,MOAB-2isselectiveforthemoreneurotoxicAβ42comparedtoAβ40.Indeed,MOAB-2demonstratedatitrationagainstantigenconcentration,anddetectsAβ40at2.5pmol,butU-,O-andF-Aβb42atantigenconcentrationsaslowas~0.1pmol(Youmans.KLetal.,2012;PMID:22423893).MOAB-2doesnotdetectAPP(AmyloidPrecursorProtein). |
| SpeciesAgainst | Human |
| AntibodyAgainst | Human |
| Cross-reactivity | Human,rat,otherspeciesnotyettested.ByDotBlot,MOAB-2detectedratAβ40andhumanAβ40,albeitwithlessaffinitythanforAβ42(YoumansKLetal.,2012). |
| BlastURL | Clickhere |
| Conjugate | Biotin |
| Form | LyophilizedfromPBSbuffer,pH7.4;containsnopreservative. |
| Appearance | Drypowder. |
| Reconstitution | Spinvialbrieflybeforeopening.Reconstitutein50µLofsterilewatertogiveaconcentrationof1mg/mL.Centrifugetoremoveanyinsolublematerial.FinalbufferisPBS,pH7.4withoutpreservative. |
| Storage | Afterreconstitutionkeepaliquotsat-20°Cto-70°Cforahigherstability.At2-8°Ckeepuptooneweek;usesterilemethodsandPipettes.Highlypurifiedglycerol(1:1)maybeaddedforanadditionalstability.Avoidrepetitivefreeze/thawcycles.Keeptightlyclosedwhennotinuseandprotectedfromlight. |
| ExpiryDate | 12monthsafterpurchase. |
| SpecificReferences | Ruan,CS.etal.(2017)Sortilininhibitsamyloidpathologybyregulatingnon-specificdegradationofAPP.ExpNeurol.[Epubaheadofprint]Application:IHC Referencesfornon-biotinylatedMOAB-2antibody(M-1586-100): Zhu,B.etal.(2017)ER-associateddegradationregulatesAlzheimer"samyloidpathologyandmemoryfunctionbymodulatingγ-secretaseactivity.NatCommun.8(1):1472.Application:IHC Huang,TY.etal.(2017)SORLAattenuatesEphA4signalingandamyloidβinducedneurodegeneration.JExpMed.pii:jem.20171413.[Epubaheadofprint].Application:IHC Felecia,M.etal.(2017)PeripheralInflammation,ApolipoproteinE4,andAmyloid-βInteracttoInduceCognitiveandCerebrovascularDysfunction.ASNNeuro.9(4):1759091417719201.Application:IHC/IF Thomas,R.etal.(2016)EpidermalgrowthfactorpreventsAPOE4andamyloid-beta-inducedcognitiveandcerebrovasculardeficitsinfemalemice.ActaNeuropatholCommun.4(1):111Application:IHC Koster,KP.etal.(2016)Epidermalgrowthfactorpreventsoligomericamyloid-βinducedangiogenesisdeficitsinvitro.JCerebBloodFlowMetab.[Epubaheadofprint]Application:IF Löffler,T.etal.(2016)DecreasedPlasmaAβinHyperlipidemicAPPSLTransgenicMiceIsAssociatedwithBBBDysfunction.Front.Neurosci.Application:IF Kobro-Flatmoen,A.etal.(2016)Reelin-immunoreactiveneuronsinentorhinalcortexlayerIIselectivelyexpressintracellularamyloidinearlyAlzheimer"sdisease.NeuroBIOLOGyofDisease.93:172-183.Application:IHC Tai,LM.etal.(2016)TheroleofAPOEincerebrovasculardysfunction.ActaNeuropathol.131(5):709-23.Application:IF Kim,YH.etal.(2015)A3DhumanneuralcellculturesystemformodelingAlzheimer"sdisease.NatProt.10(7):985-1006.Application:WB Condello,C.etal.(2015)MicrogliaconstituteabarrierthatpreventsneurotoxicprotofibrillarAβ42hotspotsaroundplaques.NatCommun.6:6176.Application:IF IulitaMFetal(2014)IntracellularAbetapathologyandearlycognitiveimpairmentsinatransgenicratmodeloverexpressinghumanamyloidprecursorprotein:amultidimensionalstudy.ActaNeuropatholCommun.6:61.Application:IF,IH SmithBRetal(2014)Neuronalinclusionsofalpha-synucleincontributetothepathogenesisofKrabbedisease.JPathol.Apr;235(5):509-21.Application:IF |
| GeneralReferences | TaiLMetal(2016)"TheroleofAPOEincerebrovasculardysfunction."ActaNeuropathol.2016Feb16.[Epubaheadofprint] TaiLMetal(2013)LevelsofsolubleapolipoproteinE/amyloid-β(Aβ)complexarereducedandoligomericAβincreasedwithAPOE4andAlzheimerdiseaseinatransgenicmousemodelandhumansamples.JBiolChem.2013Feb22;288(8):5914-26. K.L.Youmansetal(2012)IntraneuronalAbetadetectionin5xFADmicebyanewAbeta-specificantibodyMolNeurodegener.2012Mar16;7(1):8. K.L.Youmansetal(2011)Amyloid-β42altersapolipoproteinEsolubilityinbrainsofmicewithfivefamilialADmutationsJNeurosciMethods.2011Mar15;196(1):51-9. |
品牌介绍
Biosensis是一家由生命科学家和商业团队组成的公司，致力于为全球学术界和工业界的研究人员提供支持。该团队在基础和应用生命科学研究方面拥有超过100年的经验，并在生命科学研究和诊断市场的生命科学抗体，试剂和试剂盒的商业化方面拥有50多年的经验。
品牌分类
TR-200-BG型
PE-1243-50型
抗体试剂盒
PE-1246-5型
TR-100-BG型
S-1754-500型
神经营养因子
糖尿病与肥胖
细胞内贩运
电话：PE-1239-5
神经肽和受体
B-100-PS型
受体和通道分子
2个平板ELISA试剂盒
M-1763-100英尺
TR-200-BGT公司
电话：PE-1239-2
PE-1242-5型
M-1249-100号
神经营养因子受体
细胞周期调节器
S-1759-100号
PE-1606-100型
PE-1762-100型
B-200-PS型
PE-019-100型
PE-1241-5型
PE-003-100
1个平板ELISA试剂盒
BL-003-1000型
PE-1246-2型
感觉神经系统
PE-1253-100型
TR-100-FJ
BL-005-500型
神经内分泌
M-1728-100型
DNA损伤与修复
PE-001-100型
PE-1608-1型
TR-400-AG公司
PE-1243-25
细胞标记
PE-1608-5型
TR-100-FJT
自噬
PE-1242-2型
其他神经元
神经递质和酶
抗氧化酶
神经元标志物
标记抗体
BL-004-500型
PE-019-25
PE-1608-10型
BL-002-1250型
受体体嵌合体
信令与转录
基质和粘附分子
BL-001-1250型
癌症
PE-019-500
干细胞
连接蛋白
TR-300-AG型
细胞凋亡
PE-1252-100型
生长因子
发展
阿尔茨海默氏症/帕金森氏症
显示分类
联络我们
